Explore our core global industrial chemical raw materials synthesized under rigid cGMP and ISO quality standards.
In modern pharmaceutical synthesis and advanced cosmeceutical engineering, the multi-target formulation combining Tretinoin (all-trans-retinoic acid), Azelaic Acid (1,7-heptanedicarboxylic acid), and Niacinamide (Vitamin B3 / Nicotinamide) represents a golden benchmark for clinical-grade dermatological interventions. As a premier China Tretinoin Azelaic Acid And Niacinamide Manufacturer, JIMPOCHEM provides industrial partners with ultra-pure APIs engineered to satisfy stringent B2B stability and bio-availability specifications.
Tretinoin binds directly to Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs) within cell nuclei. This interaction modifies gene expression, accelerating epidermal turn-over, dissolving micro-comedones, and upregulating Type-I pro-collagen synthesis in dermal fibroblasts.
Azelaic Acid selectively acts upon hyperactive melanocytes by competitively inhibiting tyrosinase, the rate-limiting enzyme in melanin biosynthesis. Additionally, it exerts potent anti-inflammatory effects by scavenging reactive oxygen species (ROS) and suppressing 5-alpha-reductase.
Niacinamide acts as a precursor to NAD(P)H, vital for cellular energy metabolism. It inhibits the transfer of melanosomes from melanocytes to keratinocytes by up to 68%, while stimulating ceramide synthesis to preserve stratum corneum barrier integrity during retinoid therapy.
Monotherapy using potent retinoic acid derivatives often encounters compliance barriers due to Retinoid Dermatitis—characterized by erythema, transepidermal water loss (TEWL), and desquamation. Integrating high-purity Niacinamide counteracts this effect by accelerating sphingolipid and ceramide biosynthesis, bolstering the cutaneous lipid barrier. Concurrently, Azelaic Acid’s non-steroidal anti-inflammatory profile suppresses NF-kB transcription factors, neutralizing cytokine cascades triggered by retinoid application.
| Active Ingredient | CAS Number | Purity Grade (HPLC) | Primary Industrial Function | Standard Assay Range |
|---|---|---|---|---|
| Tretinoin (Retinoic Acid) | 302-79-4 | ≥ 99.2% | Cell turnover, anti-acne, anti-photoaging API | 98.0% – 102.0% (USP/EP) |
| Azelaic Acid | 123-99-9 | ≥ 99.5% | Tyrosinase inhibitor, anti-bacterial, anti-rosacea | 99.0% – 101.0% (Cosmetic/Pharma) |
| Niacinamide (Vitamin B3) | 98-92-0 | ≥ 99.8% | Melanosome block, ceramide synthesis, anti-inflammatory | 99.0% – 101.0% (USP/EP/IP) |
JIMPOCHEM CO., LTD was established in 2010 and is headquartered in the prestigious Chemical Industry Park of Jinan City, Shandong Province. Spanning an expansive area of over 500 acres, JIMPOCHEM has matured into a top-tier chemical raw material manufacturer integrating advanced R&D, large-scale industrial synthesis, commercial distribution, and technical application services.
Leveraging over 16 years of market presence, we maintain upstream control over key precursor chemicals. Our modern Jinan facility employs automated digital DCS control systems to manage batch-to-batch consistency for Tretinoin and Azelaic Acid synthesis, ensuring rapid response for high-volume orders.
Operating under the core metric that "Quality is the lifeline of an enterprise," our facilities adhere to ISO 9001 and ISO 14001 guidelines. Every manufacturing batch undergoes full-item analysis via High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and ICP-MS heavy metal validation.
Aligned with global sustainability mandates, JIMPOCHEM utilizes eco-friendly catalytic synthesis, solvent recycling units, and closed-loop wastewater management systems. Our low-carbon chemical synthesis ensures downstream client compliance with European REACH and eco-labeling standards.
Take a visual tour of our modern Jinan chemical industrial base, advanced analytical testing facilities, automated packaging lines, and partner networks:
The global demand for high-efficacy active pharmaceutical ingredients (APIs) and dermatological raw materials has surged significantly. Driven by rising consumer awareness regarding clinical-backed skincare solutions, the market valuation for retinoic acid derivatives, dicarboxylic acids, and Vitamin B3 compounds is projected to hit unprecedented growth milestones by 2030.
Strict regulatory frameworks established by the US FDA (OTC Monograph reform) and the European Chemicals Agency (ECHA / REACH) demand zero-impurity profile actives. Brands in North America and Western Europe are increasingly shifting raw material sourcing to audited Chinese manufacturers capable of supplying Drug Master Files (DMFs) and CEP/EDMF certification.
The APAC sector, particularly Southeast Asia and India, represents the fastest-growing consumer base for anti-pigmentation and anti-acne solutions. Azelaic Acid (10%-20% concentration formulations) combined with 2%-5% Niacinamide has become a dominant standard in regional cosmetic manufacturing.
As an integrated manufacturer, JIMPOCHEM delivers customized active ingredient grade options across diverse global industrial sectors:
Formulation of high-end anti-aging emulsions, brightening serums, clarifying facial cleansers, body washes, and targeted spot correctors.
Active Pharmaceutical Ingredients for prescription acne topicals, rosacea management gels, and melasma treatment creams under cGMP compliance.
Precursor supply for complex ester synthesis, fluorinated solvents, polymer stabilizers, and specialty performance chemicals.
Integrating Tretinoin, Azelaic Acid, and Niacinamide into a single cohesive vehicle presents unique chemical challenges regarding solubility, pKa variance, and photo-oxidation. JIMPOCHEM’s Technical Service Division offers customized formulation protocols to help global contract manufacturers optimize final product stability.
Azelaic Acid exhibits poor water solubility (2.4 g/L at 20°C). To overcome recrystallization and gritty sensory profiles, JIMPOCHEM provides ultra-micronized powder (D90 < 10 microns) which enhances dispersion stability in oil-in-water emulsions.
Niacinamide is most stable between pH 5.0 and 7.0 (preventing hydrolysis into Nicotinic Acid which causes skin flushing). Tretinoin requires a pH window of 5.5 to 6.5. Maintaining the final formulation at pH 5.5 – 6.0 ensures optimal chemical stability for all three active constituents.
Tretinoin is inherently susceptible to light-induced isomerization (converting to 13-cis-retinoic acid) and oxidative degradation. Our R&D team assists clients in adopting liposomal encapsulation or Solid Lipid Nanoparticles (SLN). Encapsulation shields Tretinoin from light oxidation while ensuring sustained, controlled release within the follicular infundibulum, reducing irritation markers dramatically.
JIMPOCHEM continuously invests over 8% of annual revenue into cutting-edge chemical synthesis and green transformation. Our 2025-2030 technology roadmap focuses on three strategic pillars:
Transitioning traditional chemical synthesis pathways toward enzymatic bio-fermentation for Niacinamide and dicarboxylic acid precursors, reducing carbon intensity by 42%.
Developing co-crystallized complexes of Azelaic Acid and Niacinamide that exhibit enhanced skin permeability and zero localized cytotoxicity.
Integrating blockchain-enabled batch tracking, allowing B2B buyers to verify complete COA data, raw material origin, and environmental footprints instantaneously.
Complete your procurement matrix with our reliable fine organic, fluorinated, and specialty cosmetic compounds.
JIMPOCHEM
